See every side of every news story
Get Started
SubscribeLogin
Pope Francis
Vatican
Olaf Scholz
Volodymyr Zelenskyy
Ukraine War
German Politics
Donald Trump
Israel-Hamas Conflict
Hamas
Basketball
Baseball
Wrestling
Published • loading... • Updated

BD to pay $175M to settle charges of misleading investors on Alaris pump

Summary by medtechdive.com
BD will pay a civil penalty to resolve charges it misled investors about risks associated with sales of its Alaris infusion pump, the Securities and Exchange Commission said.

7 Articles

All
Left
Center
1
Right
1
medtechdive.commedtechdive.com

BD to pay $175M to settle charges of misleading investors on Alaris pump

BD will pay a civil penalty to resolve charges it misled investors about risks associated with sales of its Alaris infusion pump, the Securities and Exchange Commission said.

Read Full Article
Seeking AlphaSeeking Alpha

Becton, Dickinson to pay $175M to settle claims over misleading investors

Becton, Dickinson settles with SEC for $175M over misleading investors on software flaws in Alaris pumps. Read more here.

·United States
Read Full Article
csimarket.comcsimarket.com

#Investor Concerns Mount as Kaspi.kz Faces Allegations of Misleading Information

In a recent announcement from the Rosen Law Firm, concerns are emerging regarding potential legal claims against Joint Stock Company Kaspi.kz (NASDAQ: KSPI), a prominent financial technology and e-commerce platform based in Kazakhstan. The law firm is encouraging investors who have experienced financial losses related to their investments in Kaspi.kz to reach out for legal support, citing allegations that the company may have disseminated materi…

Read Full Article
Constantine CannonConstantine Cannon

SEC Slaps Becton Dickinson with $175 Million Penalty for Misleading Investors About Alaris Infusion Pump - Constantine Cannon

On December 16, the Securities and Exchange Commission (SEC) announced New Jersey-based medical device maker Becton Dickinson agreed to pay $175 million to settle charges of (i) misleading investors regarding its Alaris infusion pump, and (ii) overstating its income by ignoring the costs of fixing multiple software flaws with the pump.  The pump delivers fluids, medications, and blood to hospital patients and represents roughly 10% of the compan…

Read Full Article
Malware Analysis, News and IndicatorsMalware Analysis, News and Indicators

Securities and Exchange Commission Settles Charges Against Flagstar for Misleading Investors About Citrix Data Breach

ADMINISTRATIVE PROCEEDING File No. 3-22360 December 16, 2024 – The Securities and Exchange Commission today filed settled charges against Flagstar Bancorp, Inc. (now known as “Flagstar Financial, Inc.”), for making mater…

Read Full Article
MassDeviceMassDevice

BD to pay SEC $175M to settle Alaris investigation

The Alaris infusion system [Image courtesy of BD]BD (NYSE:BDX) announced that it reached an agreement with the SEC to resolve an investigation related to its Alaris system. The investigation relates to prior public disclosures and SEC reporting regarding Alaris, an infusion pump system. BD neither admits nor denies the findings of an SEC order related to those matters occurring more than four years ago. The company has faced numerous setbacks wi…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center, 50% of the sources lean Right
50% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

LexBlog broke the news in on Monday, December 16, 2024.
Sources are mostly out of (0)

Similar News Topics

SEC

SEC

Cyber Security

Cyber Security

News
For You
Search
BlindspotLocal